Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years

被引:18
作者
Vizzotti, C. [1 ]
Gonzalez, J. [2 ,3 ]
Rearte, A. [1 ]
Uruena, A. [1 ]
Carrega, M. Perez [1 ]
Calli, R. [4 ]
Gentile, A. [5 ]
Uboldi, A. [6 ]
Ramonet, M. [7 ]
Canero-Velasco, M. [8 ]
Diosque, M. [1 ]
机构
[1] Minist Salud Nacion, Buenos Aires, DF, Argentina
[2] Inst Nacl Enfermedades Infecc, Adm Nacl Labs, Buenos Aires, DF, Argentina
[3] Inst Salud Dr Carlos Malbran, Buenos Aires, DF, Argentina
[4] Minist Salud Provincia Tucuman, Programa Ampliado Inmunizac, San Miguel De Tucuman, Argentina
[5] Hosp Ninos Dr Ricardo Gutierrez, Buenos Aires, DF, Argentina
[6] Minist Salud Provincia Santa Fe, Programa Ampliado Inmunizac, Rosario, Santa Fe, Argentina
[7] Hosp Nacl Profesor Dr Alejandro Posadas, La Plata, Buenos Aires, Argentina
[8] Hosp Ninos de San Justo, La Plata, Buenos Aires, Argentina
关键词
Argentina; hepatitis A; immunogenicity; single-dose vaccination; viral circulation; VIRUS-CIRCULATION; FOLLOW-UP; VACCINATION; CHILDREN; IMMUNOGENICITY; PREVENTION; FAILURE; INFANTS;
D O I
10.1093/jpids/piu068
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Single-dose hepatitis A virus (HAV) vaccination was implemented in all Argentinean children aged 12 months in 2005. Between 2005 and 2011, a dramatic decline was observed in HAV infection rates, fulminant hepatitis, and liver transplantation. This study assessed current viral circulation and estimated protective antibody persistence 4 years after vaccination. Methods: Prevalence of prevaccination anti-HAV antibodies in 12-month-old children was evaluated as an indirect estimation of viral circulation (Group A). Seroprevalence was also measured in 5-year-old children who received 1 dose of HAV vaccine at 1 year of age (Group B). Blood samples were tested for immunoglobulin (Ig)G anti-HAV antibodies (seroprotection = >= 10 mIU/mL). All Group A-positive samples were tested for IgM anti-HAV antibodies to identify recent infections. Logistic regression analysis was done to evaluate associations between demographic and socioeconomic variables and seroprotection. Results: Of 433 children from Group A, 29.5% (95% confidence interval [CI], 25.2-33.8) were positive for IgG anti-HAV antibodies with a geometric mean concentration (GMC) of 6.17 mIU/mL (95% CI, 5.33-7.15 mIU/mL); all IgM anti-HAV were negative. From 1139 in Group B, 93% (95% CI, 91.7-94.6) maintained seroprotection with a GMC of 97.96 mIU/mL (95% CI, 89.21-107.57 mIU/mL). Kindergarten attendance was associated with seroprotection in Group B (odds ratio [OR], 2.0; 95% CI, 1.26-3.3). In contrast, high maternal educational level was associated with a lack of seroprotection in this group (OR, .26; 95% CI, .09-.8). Conclusions: Single-dose, universal hepatitis A immunization in infants resulted in low HAV circulation and persistent immunologic protection up to 4 years in Argentina. Variables associated with presence or absence of seroprotection in vaccinated children could be related to differences in hygiene habits in settings with residual viral circulation.
引用
收藏
页码:E62 / E67
页数:6
相关论文
共 38 条
[1]  
[Anonymous], IMM BAS IMM SER
[2]  
[Anonymous], J PEDIAT GASTROEN S1
[3]  
[Anonymous], REV GASTROENTEROL PE
[4]  
[Anonymous], ACTA GASTROENT LATIN
[5]   Control of hepatitis A through routine vaccination of children [J].
Averhoff, F ;
Shapiro, CN ;
Bell, BP ;
Hyams, I ;
Burd, L ;
Deladisma, A ;
Simard, EP ;
Nalin, D ;
Kuter, B ;
Ward, C ;
Lundberg, M ;
Smith, N ;
Margolis, HS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (23) :2968-2973
[6]   The Effect of Universal Toddlers-Only Hepatitis A Virus Vaccination Program on Seropositivity Rate in Unvaccinated Toddlers Evidence for Reduced Virus Circulation in the Community [J].
Barkai, Galia ;
Belmaker, Ilana ;
Givon-Lavi, Noga ;
Dagan, Ron .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (05) :391-393
[7]   Successful booster antibody response up to 54 months after single primary vaccination with virosome-formulated, aluminum-free hepatitis A vaccine [J].
Beck, BR ;
Hatz, C ;
Brönnimann, R ;
Herzog, C .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (09) :E126-E128
[8]   Analysis of the circulation of hepatitis A virus in Argentina since vaccine introduction [J].
Blanco Fernandez, M. D. ;
Torres, C. ;
Riviello-Lopez, G. ;
Poma, H. R. ;
Rajal, V. B. ;
Nates, S. ;
Cisterna, D. M. ;
Campos, R. H. ;
Mbayed, V. A. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (12) :E548-E551
[9]   Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program [J].
Cervio, Guillermo ;
Trentadue, Julio ;
D'Agostino, Daniel ;
Luque, Carlos ;
Giorgi, Mariano ;
Armoni, Judith ;
Debbag, Roberto .
HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2011, 3 :99-106
[10]   Long-term follow-up of hepatitis A vaccination in children [J].
Chan, CY ;
Lee, SD ;
Yu, MI ;
Wang, YJ ;
Chang, FY ;
Lo, KJ .
VACCINE, 1999, 17 (04) :369-372